NCT03675412View on ClinicalTrials.gov

Caffeine Consumption in Glaucoma Patients and Healthy Subjects

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 30, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Glaucoma, Primary Open Angle
Interventions
DIETARY_SUPPLEMENT

Caffeine tablet

Each eligible participant will receive one 200 mg caffeine tablet to ingest after completing all baseline study tasks.

Trial Locations (1)

19107

RECRUITING

Wills Eye Glaucoma Service, Philadelphia

All Listed Sponsors
lead

Wills Eye

OTHER